Insuman Infusat (Insulin Human)

Insuman Infusat is an insulin analogue that lowers blood glucose by acting on the insulin pathway.

• Diabetes mellitus type 1: provides basal insulin to replace the absent endogenous hormone and maintain glycaemic control.
• Diabetes mellitus type 2: used as part of a regimen when oral agents are insufficient to achieve target glucose levels.

• Insulin human binds to insulin receptors on cell membranes, triggering intracellular signaling cascades that promote translocation of GLUT‑4 transporters, increase glucose uptake in muscle and adipose tissue, suppress hepatic gluconeogenesis, and stimulate glycogen synthesis, thereby reducing circulating blood glucose concentrations.

Insuman Infusat may be associated with a range of adverse reactions.

Common Side Effects

• Hypoglycaemia: low blood sugar episodes, especially if dosing is mismatched with food intake.
• Injection site reactions: redness, swelling, or itching at the injection site.
• Lipodystrophy: localized changes in fat tissue with repeated injections.
• Weight gain: modest increase due to improved glucose utilization.
• Edema: mild fluid retention, particularly in the lower extremities.

Serious or Rare Side Effects

• Severe hypoglycaemia leading to loss of consciousness or seizures.
• Allergic reactions: urticaria, angioedema, or anaphylaxis.
• Hypersensitivity at the injection site with necrosis.
• Persistent hyperglycaemia indicating treatment failure.
• Unexplained weight loss despite adequate dosing.

When using Insuman Infusat, consider the following safety measures.

• Dose individualisation: titrate based on blood glucose monitoring and clinical response.
• Hypoglycaemia risk: educate patients on recognising and treating low blood sugar.
• Renal impairment: adjust dose and monitor renal function regularly.
• Concomitant medications: review for agents that may potentiate hypoglycaemia.
• Pregnancy and lactation: evaluate risk‑benefit ratio with a healthcare professional.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Infusat can interact with several drug classes.

Major Interactions (Avoid)

• Beta‑blockers: may mask hypoglycaemia symptoms and prolong its duration.
• MAO‑inhibitors: can potentiate insulin’s glucose‑lowering effect.
• Sulfonylureas: combined use increases risk of severe hypoglycaemia.

Moderate Interactions (Monitor Closely)

• Thiazide diuretics: may raise blood glucose levels, requiring dose adjustment.
• Corticosteroids: can induce hyperglycaemia, necessitating higher insulin doses.
• Oral contraceptives: may slightly alter insulin requirements.